mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids

Davies RJ et al. – Significant weight loss is achievable over 6 weeks in a diet–specific trial in subjects with stable systemic lupus erythematosus (SLE), who are on low dose prednisolone. Both diets were equally tolerable, and did not cause flares in disease activity. The results suggest that dietary manipulation may significantly improve fatigue in subjects with SLE.

Methods
  • A total of 23 women were enrolled in a 6 week study.
  • All had mild, stable SLE, were receiving corticosteroids and had a body mass index > 25 kg/m2.
  • Subjects were randomly assigned to a low glycaemic index (Low GI) diet or a calorie restricted (Low Cal) diet.
  • The primary end point was weight loss.
  • Secondary end points included tolerability of diet, bio–markers of cardiovascular risk, disease activity, fatigue and sleep quality.

Results
  • Weight loss in both treatment groups was significant (mean ± SD: Low GI diet 3.9 ± 0.9 kg; Low Cal diet 2.4 ± 2.2 kg, p < 0.01 from baseline in each group).
  • There were also significant improvements in waist and hip measurements.
  • However, the difference in weight loss and waist and hip measurements between the two diet groups was not statistically significant.
  • There was a statistically significant reduction in Fatigue Severity Scale in both diet groups, (p < 0.03).
  • Both Low GI and Low Cal diets were well tolerated, resulting in no serious adverse effects or increase in disease activity.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close